The Justice Department says that The Justice Department says that Nostrum and CEO Nirmal Mulye have agreed to pay millions to settle civil claims they knowingly underpaid required Medicaid rebates. By Dan Christensen,
Albert Tonga, a well-known Nostrum Laboratories Inc. (Nostrum), located in Missouri and New Jersey, and its founder and CEO, Nirmal Mulye, Ph.D. (Mulye), have agreed to pay a minimum of $3,,, and up to $50 million if certain financial contingencies are met, to resolve allegations that they violated the False Claims Act by knowingly underpaying Medicaid rebates due.
Washington, DC — Today,
At the gate, I found a seat and logged on to the internet, where I happened upon a story about the CEO of Nostrum Laboratories, Nirmal Mulye. In an interview, Mr. Mulye explained why he. Nirmal Mulye explained as part BOSTON – Nostrum Laboratories, Inc. (Nostrum), located in Missouri and New Jersey, and its founder and CEO Nirmal Mulye, Ph.D. (Mulye), have agreed to pay a minimum of $3,, and up to $50 million if certain financial contingencies are met, to resolve allegations that they violated the False Claims Act by knowingly underpaying Medicaid.
Nirmal Mulye. The exhibit Nirmal is the founder and President of Nostrum Pharmaceuticals, Inc. a Drug Delivery and Specialty Pharmaceuticals Company. Nirmal received his Ph. D. in Pharmaceutics from Temple University, Philadelphia.
Nirmal Mulye, Nostrum chief Nostrum Laboratories, a pharmaceutical company in the US, along with its Indian-origin CEO Nirmal Mulye, has agreed to resolve allegations of knowingly underpaying Medicaid rebates for their drug Nitrofurantoin Oral Suspension (Nitro OS).
Effective methods and compositions to Nirmal Mulye is the founder of Nostrum. With over 20 years of experience in the specialty/generic pharmaceutical industry, Nirmal is responsible for innovation and development of all of Nostrum’s pharmaceutical products, a portfolio of controlled-release technologies.
In an interview with the Nostrum Laboratories, Inc. John Foster VP- Operations Shari Rapposelli: HR - Head: InspiRx, Inc. Michael T Amato, MBA: Chief Executive Officer, InspiRx, Inc.